维普中文期刊产品整合服务
10篇 您的检索式:作者名="Porter CB"
    题名 作者 年代 出处 被引量
1Vohagegated K(+)-channel activity in ovine pulmonary vasculature is developmentally regulated显示文摘Cornfield DN Saqueton CB Porter VA 2000Am J Physiol Lung Cell Mol Physiol2000,278,6:1
2Epinephrine-induced QT interval prolongation:a gene-specific paradoxical response in congenital long QT syndrome显示文摘Ackerman MJ Khositseth A Tester DJ Hejlik JB Shen WK Porter CB 2002Mayo Clin Proc2002,77,5:1
3Development and evaluation of the Kansas city cardiomyopathy questionnaire: a new health status measure for heart failure 显示文摘Green CP Porter CB Bresnahan DR 2000J Am Coll Gardiol2000,35,5:1
4Development and evaluation of the Kansas city cardiomyopathy questionnaire: a new health status measure for heart failure显示文摘Green CP Porter CB Bresnahan DR 2000J Am Coll Cardial2000,35,:1
5Outcome of fetuses with a prenatal ultrasound diagnosis of isolated omphalocele 显示文摘Porter A Benson CB Hawley P 2009Prenat Diagn2009,29,7:1
6Rapid Genomic Evolution of a Non-virulent Coxsackievirus B3 in Selenium-deficient Mice显示文摘Keshan disease, an endemic cardiomyopathy in China, can be prevented with selenium (Se) supplementation. However, the seasonal and annual nature of the disease suggests that an infectious co-factor is required along with a deficiency in Se. Using a murine model of coxsackievirus B3 (CVB3) -induced myocarditis, Se-deficient mice were shown to be more susceptible to the cardiopathologic effects of the virus. In addition, a normall benign strain of CVB3 becomes virulent in Se-deficient mice. This change in virulence was shown to be due to point mutations in the viral genorne. Although the mechanism of the viral mutation is not known, the oxidative stress status of the Se-deficient host may play a role, either by directly affecting the virus and/or affecting host immuneMELINDA A. BECK(University of North Carolina at Chapel Hill,Frank Porter Graham Child Development Center, 105 Smith Level Rd, CB # 8180,Chapel Hill, NC 27599-8180, USA) 1997Biomedical and Environmental Sciences1997,10,2:1
7Nine-year follow-up of a patient with attenuated familial adenomatous polyposis treated with eyelo-oxygenase-2 inhibitors 显示文摘Ferguson CB Porter KG Murphy SJ 2008Stand J Gastroenterol2008,43,12:1
8Orthostatic heart rate and blood pressure in adolescents: reference ranges 显示文摘Skinner JE Driscoll SW Porter CB 2010J Child Neurol2010,25,10:1
9Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure显示文摘Green CP Porter CB Bresnahan DR 2000J Am Coll Cardiol2000,35,:1
10Sudden cardiac death and channelopathies:a review of implantable defibrillator therapy显示文摘Choi GR Porter CB Ackerman MJ 0,,05:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费